Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Brain Responses in Addicted Mothers
NCT02979093Phase 2Terminated
- Start
- May 2017
- Primary completion
- May 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in substance use disorder (SUD). Primary endpoint: Effect of Intranasal Oxytocin on Brain fMRI Activation, Independent of Addiction Status at 50 months. Started May 2017; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
substance use disorder (SUD)
Beyond the preview
Go deeper on NCT02979093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979093.